Emergent Biosolutions Inc (EBS)
Cash & Equivalents
$139.70M
Quarterly · Period ending: · USD
EBS Cash & Equivalents
Latest reported$139.70Mperiod ending
Latest reported$139.70Mperiod ending
EBS Quarterly Cash & Equivalents ($642.60M → $139.70M)
Quarterly Cash & Equivalents
High-resolution chart · PNG
EBS cash & equivalents history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cash & Equivalents (USD) |
|---|---|
| 139,700,000 | |
| 160,300,000 | |
| 205,400,000 | |
| 245,500,000 | |
| 271,000,000 | |
| 149,100,000 | |
| 105,600,000 | |
| 149,900,000 | |
| 69,700,000 | |
| 79,000,000 | |
| 111,700,000 | |
| 87,800,000 | |
| 88,600,000 | |
| 430,200,000 | |
| 642,600,000 | |
| 241,000,000 | |
| 358,100,000 | |
| 435,800,000 | |
| 576,300,000 | |
| 404,000,000 | |
| 447,700,000 | |
| 548,000,000 | |
| 621,300,000 | |
| 415,000,000 | |
| 269,000,000 | |
| 181,700,000 | |
| 168,000,000 | |
| 139,200,000 | |
| 177,400,000 | |
| 137,200,000 | |
| 112,200,000 | |
| 339,358,000 | |
| 190,237,000 | |
| 163,606,000 | |
| 178,292,000 | |
| 340,991,000 | |
| 315,627,000 | |
| 270,170,000 | |
| 271,513,000 | |
| 298,932,000 | |
| 333,395,000 | |
| 341,016,000 | |
| 312,795,000 | |
| 308,718,000 | |
| 214,841,000 | |
| 216,515,000 | |
| 280,499,000 | |
| 242,249,000 | |
| 168,130,000 | |
| 160,215,000 | |
| 179,338,000 | |
| 172,561,000 | |
| 156,243,000 | |
| 130,238,000 | |
| 141,666,000 | |
| 197,901,000 | |
| 161,843,000 | |
| 150,425,000 | |
| 143,901,000 | |
| 125,346,000 | |
| 122,094,000 | |
| 136,925,000 | |
| 169,019,000 | |
| 151,229,000 | |
| 102,193,000 | |
| 116,384,000 | |
| 102,924,000 | |
| 118,777,000 | |
| 102,508,000 | |
| 61,380,000 | |
| 91,473,000 | |
| 104,688,000 | |
| 84,007,000 | |
| 92,747,000 | |
| 105,730,000 | |
| 24,266,000 | |
| 33,980,000 | |
| 67,645,000 | |
| 76,418,000 | |
| 19,906,000 | |
| 36,294,000 | |
| 6,821,000 | |
| 576,100,000 | |
| 642,600,000 |